India's GDP may be impacted by proposed US tariffs raising by an estimated 0.1 to 0.6 percentage points, as per Goldman Sachs ...

India and Japan have a unique opportunity to gain from US tariffs, says Hero Enterprises' Sunil Kant Munjal. He believes ...

The Indian stock market has seen a dramatic downturn in 2025, with major indices losing substantial value. Investors are ...

S&P Global Ratings reports that India, South Korea, and Thailand are most at risk of facing higher US tariffs under the Trump ...

Trump criticised the $21 million in USAID funding for India’s voter turnout. He raised concerns about transparency and ...

The India-US ties will depend on India's readiness to be a willing partner in the American designs on China and what it will ...

The market participants are expected to maintain cautious stance in the truncated week ahead starting from February 24, with ...

Indian indices Sensex and Nifty opened lower, mirroring global market downturn fueled by US inflation concerns and FII ...

Zydus Lifesciences: The company and its subsidiaries received final approval from the United States Food and Drug Administration (US FDA) to manufacture Ibuprofen and Famotidine tablets, 800 mg/26.6 ...

A former KGB officer claims Donald Trump was recruited as a Russian spy in 1987, codenamed 'Krasnov'. Trump allegedly became ...

US President Donald Trump has ramped up his attack on USAID funds given to India, claiming the grant is misused to boost ...

Out of the 30 Sensex shares, 28 were in red with Zomato, HCL Tech, PowerGrid, HDFC Bank, and IndusInd Bank being the biggest losers falling up to 2 per cent.